Table 3 Potential effects of SOP on diagnosis of SCI-AP, antibiotic treatment decision, and request of further diagnostic tests based on the eight case vignettes.
From: Clinical decision-making on spinal cord injury-associated pneumonia: a nationwide survey in Germany
Case | Diagnosis of SCI-AP | Treatment of SCI-AP | Further diagnostics | ||||||
|---|---|---|---|---|---|---|---|---|---|
SOP+,n (%) | SOP−, n (%) | Odds ratio (95% CI) | SOP+, n (%) | SOP−, n (%) | Odds ratio (95% CI) | SOP+, n (%) | SOP− n (%) | Odds ratio (95% CI) | |
I | 28 (78.0) | 16 (84.2) | 0.65 (0.15–2.83) | 28 (78.0) | 16 (84.2) | 0.66 (0.15–2.83) | 29 (80.5) | 13 (68.4) | 1.91 (0.54–6.82) |
II | 18 (50.0) | 14 (73.7) | 0.35 (0.11–1.20) | 17 (47.2) | 13 (68.4) | 0.41 (0.13–1.32) | 32 (88.9) | 15 (78.9) | 2.13 (0.47–9.71) |
III | 4 (11.0) | 1 (5.3) | 2.25 (0.23–21.71) | 7 (19.4) | 4 (21.1) | 0.91 (0.23–3.59) | 22 (61.1) | 15 (78.9) | 0.42 (0.12–1.52) |
IV | 5 (14.0) | 6 (31.6) | 0.34 (0.09–1.35) | 6 (16.7) | 5 (26.3) | 0.56 (0.15–2.15) | 22 (61.1) | 14 (73.7) | 0.56 (0.17–1.90) |
V | 11 (31.0) | 10 (52.6) | 0.40 (0.13–1.25) | 10 (27.8) | 7 (36.8) | 0.66 (0.20–2.15) | 27 (75.0) | 12 (63.2) | 1.75 (0.53–5.81) |
VI | 2 (6.0) | 2 (10.5) | 0.50 (0.65–3.86) | 8 (22.3) | 8 (42.1) | 0.39 (0.12–1.31) | 23 (63.9) | 12 (63.2) | 1.03 (0.32–3.27) |
VII | 16 (44.0) | 7 (36.8) | 1.37 (0.44–4.29) | 11 (33.4) | 7 (36.8) | 0.75 (0.23–2.43) | 27 (75.0) | 12 (63.2) | 1.75 (0.53–5.08) |
VIII | 18 (50.0) | 9 (47.4) | 1.11 (0.37–3.38) | 17 (47.2) | 9 (47.4) | 0.99 (0.33–3.03) | 23 (63.9) | 11 (57.9) | 1.29 (0.41–4.01) |
